Profile data is unavailable for this security.
About the company
Ascentage Pharma Group International is an investment holding company principally engaged in developing novel small therapies for cancers, hepatitis B virus (HBV) and certain age-related diseases. The Company focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis, or programmed cell death. The Company's main products include the next-generation kinase inhibitor: HQP1351 and apoptosis targeted drugs APG-1252, APG2575, APG-115 and so on. The Company conducts businesses within the domestic market and to overseas markets, including the United States.
- Revenue in HKD (TTM)239.39m
- Net income in HKD-998.20m
- Incorporated2017
- Employees583.00
- LocationAscentage Pharma Group International218 Xinghu StreetBuilding B7, 7th FloorSuzhou ChinaCHN
- Websitehttps://www.ascentage.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biocytogen Pharmaceuticals Beijng Co Ltd | 773.11m | -412.97m | 3.82bn | 1.07k | -- | 4.51 | -- | 4.94 | -1.04 | -1.04 | 1.94 | 2.12 | 0.2732 | 16.21 | 5.74 | 725,248.20 | -14.59 | -- | -18.88 | -- | 70.59 | -- | -53.42 | -- | 1.24 | -21.30 | 0.4077 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
| CK Life Sciences Intl (Holdings) Inc | 5.32bn | 17.25m | 3.84bn | 1.93k | 223.46 | 0.9177 | 33.91 | 0.7223 | 0.0018 | 0.0018 | 0.5538 | 0.4359 | 0.4728 | 2.96 | 4.74 | 2,755,038.00 | 0.1532 | 1.11 | 0.211 | 1.43 | 30.76 | 30.52 | 0.3241 | 2.42 | 0.8512 | 0.8796 | 0.5861 | 59.00 | 0.8936 | 0.3407 | -86.93 | -42.01 | 0.2784 | -- |
| CARsgen Therapeutics Holdings Ltd | 0.00 | -806.42m | 3.85bn | 516.00 | -- | 1.98 | -- | -- | -1.45 | -1.45 | 0.00 | 3.38 | 0.00 | -- | -- | 0.00 | -29.79 | -- | -32.14 | -- | -- | -- | -- | -- | 9.54 | -- | 0.0452 | -- | -- | -- | 16.19 | -- | -- | -- |
| Jiangsu Recbio Technology Co Ltd | 0.00 | -616.80m | 4.27bn | 472.00 | -- | 3.67 | -- | -- | -1.28 | -1.28 | 0.00 | 2.41 | 0.00 | -- | -- | 0.00 | -25.47 | -- | -30.68 | -- | -- | -- | -- | -- | 2.33 | -- | 0.378 | -- | -- | -- | 20.86 | -- | -- | -- |
| Alphamab Oncology | 235.92m | -227.10m | 4.51bn | 435.00 | -- | 2.50 | -- | 19.10 | -0.2362 | -0.2362 | 0.2458 | 1.87 | 0.1028 | 0.7705 | 19.34 | 542,356.00 | -9.90 | -18.72 | -11.69 | -21.94 | 74.75 | -- | -96.26 | -415.55 | 5.55 | -- | 0.1333 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
| Shandong Boan Biotechnology Co Ltd | 666.59m | -128.74m | 4.81bn | 813.00 | -- | 3.38 | -- | 7.21 | -0.2528 | -0.2528 | 1.31 | 2.79 | 0.2732 | 1.35 | 2.53 | 819,910.80 | -5.28 | -- | -7.02 | -- | 66.16 | -- | -19.31 | -- | 0.8383 | -7.47 | 0.2491 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -268.90m | 4.84bn | 133.00 | -- | 4.40 | -- | -- | -1.34 | -1.34 | 0.00 | 5.44 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 6.41 | -- | 0.0185 | -- | -- | -- | 65.62 | -- | -- | -- |
| Ocumension Therapeutics | 265.68m | -409.56m | 4.86bn | 444.00 | -- | 1.53 | -- | 18.28 | -0.6312 | -0.6312 | 0.4093 | 4.56 | 0.078 | 3.61 | 2.12 | 598,380.70 | -12.03 | -38.78 | -13.21 | -41.47 | 58.60 | 62.30 | -154.16 | -975.82 | 3.72 | -- | 0.0451 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
| Microport NeuroTech Ltd | -100.00bn | -100.00bn | 5.24bn | 571.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 21.61 | -- | 768.73 | -- | -- | -- |
| Ascentage Pharma Group International | 239.39m | -998.20m | 5.29bn | 583.00 | -- | 81.15 | -- | 22.09 | -3.53 | -3.53 | 0.848 | 0.2245 | 0.0833 | 2.38 | 2.22 | 410,611.50 | -34.73 | -44.93 | -52.82 | -57.04 | 86.24 | 87.68 | -417.02 | -976.10 | 1.42 | -15.03 | 0.9622 | -- | 5.85 | 100.76 | -4.84 | -- | 2.82 | -- |
| Sihuan Pharmaceutical Holdings Group Ltd | 2.01bn | -58.25m | 5.32bn | 2.87k | -- | 1.11 | -- | 2.65 | -0.0063 | -0.0063 | 0.2158 | 0.5123 | 0.1572 | 0.8101 | 4.72 | 698,606.10 | -2.18 | -6.85 | -3.34 | -9.10 | 69.64 | 75.81 | -13.85 | -36.23 | 1.35 | -2.63 | 0.1863 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | -100.00bn | -100.00bn | 5.46bn | 145.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -28.25 | -- | 5.82 | -- | -- | -- |
| Consun Pharmaceutical Group Ltd | 2.79bn | 846.04m | 5.46bn | 3.13k | 6.31 | 1.39 | 5.86 | 1.96 | 1.06 | 1.06 | 3.50 | 4.82 | 0.4981 | 2.08 | 9.10 | 893,242.10 | 15.13 | 12.04 | 22.57 | 19.25 | 74.19 | 74.55 | 30.37 | 24.89 | 2.62 | -- | 0.1155 | 41.53 | 10.71 | 7.03 | 14.88 | 11.01 | -- | 18.43 |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 872.67m | 110.20m | 6.19bn | 948.00 | 19.61 | 0.8553 | -- | 7.09 | 0.1071 | 0.1071 | 0.8287 | 2.46 | 0.2852 | 1.44 | 1.62 | 920,541.00 | 3.59 | 7.03 | 4.35 | 9.05 | 91.40 | 92.17 | 12.59 | 17.26 | 3.94 | 568.37 | 0.0062 | 39.16 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | 0.00 |
| Qyuns Therapeutics Co Ltd | 0.00 | -547.55m | 6.24bn | 331.00 | -- | 19.63 | -- | -- | -2.47 | -2.47 | 0.00 | 1.43 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 1.64 | -69.52 | 0.5349 | -- | -- | -- | -70.28 | -- | -- | -- |
| New Horizon Health Ltd | 1.47bn | 119.30m | 6.47bn | 1.04k | 59.24 | 2.01 | 41.66 | 4.41 | 0.2387 | 0.2387 | 3.22 | 7.04 | 0.4536 | 2.16 | 2.08 | 1,672,843.00 | 3.67 | -- | 3.99 | -- | 88.74 | -- | 8.10 | -- | 10.50 | -- | 0.1305 | -- | 259.54 | -- | 97.40 | -- | -- | -- |
Data as of May 27 2024. Currency figures normalised to Ascentage Pharma Group International's reporting currency: Hong Kong Dollar HKD
6.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 09 May 2024 | 6.40m | 2.21% |
| BlackRock Fund Advisorsas of 09 May 2024 | 3.07m | 1.06% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 2.16m | 0.75% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 1.44m | 0.50% |
| Harvest Fund Management Co., Ltd.as of 31 Dec 2023 | 1.32m | 0.46% |
| BlackRock Advisors (UK) Ltd.as of 09 May 2024 | 830.80k | 0.29% |
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 629.17k | 0.22% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 611.70k | 0.21% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 559.00k | 0.19% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 458.80k | 0.16% |
More ▼
Data from 31 Dec 2023 - 22 May 2024Source: FactSet Research Systems Inc.
